ROYAL BANK OF CANADA
BankPosition in ZYBT — Zhengye Biotechnology Holding Ltd
CIK 1000275
TORONTO, A6
Position in ZYBT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,150
+$710 QoQ
Shares Held
1,230
+221.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 7 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $672,203,105 across 64 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,974,284 | $233,380,104 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
9,984,082 | $138,279,533 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
11,363,498 | $61,362,887 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
332,300 | $43,777,199 | |
| 5 | VTRS |
Viatris Inc
|
2,907,645 | $39,282,278 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
59,152 | $35,075,949 | |
| 7 | HLN |
Haleon plc
|
3,063,916 | $30,669,795 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
963,824 | $29,030,375 |
All Filings in ZYBT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,150 | 1,230 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $440 | 383 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $202 | 34 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||